Refine your search
-
Authors
-
Item types
-
Topics
- *Cost-Benefit Analysis
- *Eicosapentaenoic Acid/aa [Analogs & Derivatives]
- *Eicosapentaenoic Acid/ec [Economics]
- *Eicosapentaenoic Acid/tu [Therapeutic Use]
- *Hydroxymethylglutaryl-CoA Reductase Inhibitors/ec [Economics]
- *Hydroxymethylglutaryl-CoA Reductase Inhibitors/tu [Therapeutic Use]
- *Hyperlipidemias/dt [Drug Therapy]
- *Hyperlipidemias/ec [Economics]
- *Hypertriglyceridemia/dt [Drug Therapy]
- Aged
- Drug Dosage Calculations
- Eicosapentaenoic Acid/aa [Analogs & Derivatives]
- Eicosapentaenoic Acid/ad [Administration & Dosage]
- Eicosapentaenoic Acid/ae [Adverse Effects]
- Eicosapentaenoic Acid/tu [Therapeutic Use]
- Female
- Humans
- Male
- Middle Aged
- Risk Factors
- Show more
- Show less
-
Collections
-
Languages